Logo image of SMG

SCOTTS MIRACLE-GRO CO (SMG) Stock Fundamental Analysis

NYSE:SMG - New York Stock Exchange, Inc. - US8101861065 - Common Stock - Currency: USD

58.45  -1.52 (-2.53%)

After market: 58.45 0 (0%)

Fundamental Rating

4

SMG gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 85 industry peers in the Chemicals industry. There are concerns on the financial health of SMG while its profitability can be described as average. SMG has a correct valuation and a medium growth rate. Finally SMG also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

SMG had positive earnings in the past year.
In the past year SMG had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: SMG reported negative net income in multiple years.
Of the past 5 years SMG 4 years had a positive operating cash flow.
SMG Yearly Net Income VS EBIT VS OCF VS FCFSMG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M 600M

1.2 Ratios

SMG has a Return On Assets (1.02%) which is comparable to the rest of the industry.
Looking at the Return On Invested Capital, with a value of 12.51%, SMG belongs to the top of the industry, outperforming 94.12% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for SMG is above the industry average of 6.66%.
The last Return On Invested Capital (12.51%) for SMG is above the 3 year average (10.63%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 1.02%
ROE N/A
ROIC 12.51%
ROA(3y)-7.51%
ROA(5y)-0.08%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)10.63%
ROIC(5y)13.54%
SMG Yearly ROA, ROE, ROICSMG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200

1.3 Margins

Looking at the Profit Margin, with a value of 1.04%, SMG is in line with its industry, outperforming 51.76% of the companies in the same industry.
Looking at the Operating Margin, with a value of 11.57%, SMG is in the better half of the industry, outperforming 64.71% of the companies in the same industry.
In the last couple of years the Operating Margin of SMG has declined.
Looking at the Gross Margin, with a value of 28.78%, SMG is in line with its industry, outperforming 55.29% of the companies in the same industry.
In the last couple of years the Gross Margin of SMG has declined.
Industry RankSector Rank
OM 11.57%
PM (TTM) 1.04%
GM 28.78%
OM growth 3Y-13.17%
OM growth 5Y-5.28%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.65%
GM growth 5Y-4.15%
SMG Yearly Profit, Operating, Gross MarginsSMG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

3

2. Health

2.1 Basic Checks

SMG has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, SMG has more shares outstanding
SMG has more shares outstanding than it did 5 years ago.
SMG has a worse debt/assets ratio than last year.
SMG Yearly Shares OutstandingSMG Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
SMG Yearly Total Debt VS Total AssetsSMG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

An Altman-Z score of 2.27 indicates that SMG is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.27, SMG is in the better half of the industry, outperforming 67.06% of the companies in the same industry.
The Debt to FCF ratio of SMG is 6.67, which is on the high side as it means it would take SMG, 6.67 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of SMG (6.67) is better than 71.76% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 6.67
Altman-Z 2.27
ROIC/WACC1.39
WACC8.98%
SMG Yearly LT Debt VS Equity VS FCFSMG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B

2.3 Liquidity

SMG has a Current Ratio of 1.71. This is a normal value and indicates that SMG is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of SMG (1.71) is worse than 61.18% of its industry peers.
A Quick Ratio of 0.94 indicates that SMG may have some problems paying its short term obligations.
With a Quick ratio value of 0.94, SMG is not doing good in the industry: 69.41% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.71
Quick Ratio 0.94
SMG Yearly Current Assets VS Current LiabilitesSMG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 89.33% over the past year.
SMG shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -12.83% yearly.
SMG shows a decrease in Revenue. In the last year, the revenue decreased by -2.05%.
SMG shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.40% yearly.
EPS 1Y (TTM)89.33%
EPS 3Y-37.53%
EPS 5Y-12.83%
EPS Q2Q%12.12%
Revenue 1Y (TTM)-2.05%
Revenue growth 3Y-10.32%
Revenue growth 5Y2.4%
Sales Q2Q%-1.18%

3.2 Future

Based on estimates for the next years, SMG will show a very strong growth in Earnings Per Share. The EPS will grow by 25.19% on average per year.
The Revenue is expected to grow by 0.65% on average over the next years.
EPS Next Y59.93%
EPS Next 2Y39.1%
EPS Next 3Y32.31%
EPS Next 5Y25.19%
Revenue Next Year-2.96%
Revenue Next 2Y-0.48%
Revenue Next 3Y0.4%
Revenue Next 5Y0.65%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
SMG Yearly Revenue VS EstimatesSMG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1B 2B 3B 4B
SMG Yearly EPS VS EstimatesSMG Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6 8

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 17.34, SMG is valued on the expensive side.
Compared to the rest of the industry, the Price/Earnings ratio of SMG indicates a somewhat cheap valuation: SMG is cheaper than 61.18% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.48, SMG is valued a bit cheaper.
With a Price/Forward Earnings ratio of 13.49, SMG is valued correctly.
The rest of the industry has a similar Price/Forward Earnings ratio as SMG.
The average S&P500 Price/Forward Earnings ratio is at 34.04. SMG is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 17.34
Fwd PE 13.49
SMG Price Earnings VS Forward Price EarningsSMG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SMG is on the same level as its industry peers.
87.06% of the companies in the same industry are more expensive than SMG, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 8.83
EV/EBITDA 12.36
SMG Per share dataSMG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

SMG's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as SMG's earnings are expected to grow with 32.31% in the coming years.
PEG (NY)0.29
PEG (5Y)N/A
EPS Next 2Y39.1%
EPS Next 3Y32.31%

7

5. Dividend

5.1 Amount

SMG has a Yearly Dividend Yield of 4.40%, which is a nice return.
SMG's Dividend Yield is rather good when compared to the industry average which is at 3.76. SMG pays more dividend than 83.53% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.39, SMG pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.4%

5.2 History

The dividend of SMG has a limited annual growth rate of 3.51%.
SMG has paid a dividend for at least 10 years, which is a reliable track record.
SMG has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)3.51%
Div Incr Years0
Div Non Decr Years3
SMG Yearly Dividends per shareSMG Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6

5.3 Sustainability

424.10% of the earnings are spent on dividend by SMG. This is not a sustainable payout ratio.
SMG's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP424.1%
EPS Next 2Y39.1%
EPS Next 3Y32.31%
SMG Yearly Income VS Free CF VS DividendSMG Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M
SMG Dividend Payout.SMG Dividend Payout, showing the Payout Ratio.SMG Dividend Payout.PayoutRetained Earnings

SCOTTS MIRACLE-GRO CO

NYSE:SMG (8/8/2025, 8:06:54 PM)

After market: 58.45 0 (0%)

58.45

-1.52 (-2.53%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)07-30 2025-07-30/bmo
Earnings (Next)11-05 2025-11-05/amc
Inst Owners74.67%
Inst Owner Change-0.27%
Ins Owners0.55%
Ins Owner Change-0.48%
Market Cap3.37B
Analysts77.14
Price Target77.18 (32.04%)
Short Float %9.58%
Short Ratio4.75
Dividend
Industry RankSector Rank
Dividend Yield 4.4%
Yearly Dividend2.66
Dividend Growth(5Y)3.51%
DP424.1%
Div Incr Years0
Div Non Decr Years3
Ex-Date08-22 2025-08-22 (0.66)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)14.09%
Min EPS beat(2)-0.27%
Max EPS beat(2)28.45%
EPS beat(4)2
Avg EPS beat(4)7.53%
Min EPS beat(4)-16.32%
Max EPS beat(4)28.45%
EPS beat(8)5
Avg EPS beat(8)3.55%
EPS beat(12)8
Avg EPS beat(12)6.26%
EPS beat(16)11
Avg EPS beat(16)4.88%
Revenue beat(2)1
Avg Revenue beat(2)-0.42%
Min Revenue beat(2)-6.02%
Max Revenue beat(2)5.18%
Revenue beat(4)2
Avg Revenue beat(4)0.31%
Min Revenue beat(4)-6.02%
Max Revenue beat(4)5.18%
Revenue beat(8)4
Avg Revenue beat(8)0.98%
Revenue beat(12)5
Avg Revenue beat(12)-0.4%
Revenue beat(16)7
Avg Revenue beat(16)0.56%
PT rev (1m)5.83%
PT rev (3m)12.66%
EPS NQ rev (1m)0.06%
EPS NQ rev (3m)1.56%
EPS NY rev (1m)0%
EPS NY rev (3m)6.13%
Revenue NQ rev (1m)-0.16%
Revenue NQ rev (3m)-0.32%
Revenue NY rev (1m)-0.17%
Revenue NY rev (3m)0.03%
Valuation
Industry RankSector Rank
PE 17.34
Fwd PE 13.49
P/S 0.98
P/FCF 8.83
P/OCF 7.51
P/B N/A
P/tB N/A
EV/EBITDA 12.36
EPS(TTM)3.37
EY5.77%
EPS(NY)4.33
Fwd EY7.42%
FCF(TTM)6.62
FCFY11.32%
OCF(TTM)7.78
OCFY13.32%
SpS59.85
BVpS-5.03
TBVpS-16.39
PEG (NY)0.29
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.02%
ROE N/A
ROCE 15.83%
ROIC 12.51%
ROICexc 12.59%
ROICexgc 17.05%
OM 11.57%
PM (TTM) 1.04%
GM 28.78%
FCFM 11.05%
ROA(3y)-7.51%
ROA(5y)-0.08%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)10.63%
ROIC(5y)13.54%
ROICexc(3y)10.91%
ROICexc(5y)13.96%
ROICexgc(3y)15.3%
ROICexgc(5y)22.83%
ROCE(3y)13.46%
ROCE(5y)17.14%
ROICexcg growth 3Y-10.58%
ROICexcg growth 5Y-6.7%
ROICexc growth 3Y-7.68%
ROICexc growth 5Y0%
OM growth 3Y-13.17%
OM growth 5Y-5.28%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.65%
GM growth 5Y-4.15%
F-Score7
Asset Turnover0.98
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 6.67
Debt/EBITDA 5.22
Cap/Depr 86.08%
Cap/Sales 1.95%
Interest Coverage 2.81
Cash Conversion 94.02%
Profit Quality 1057.89%
Current Ratio 1.71
Quick Ratio 0.94
Altman-Z 2.27
F-Score7
WACC8.98%
ROIC/WACC1.39
Cap/Depr(3y)104.14%
Cap/Depr(5y)98.52%
Cap/Sales(3y)2.62%
Cap/Sales(5y)2.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)89.33%
EPS 3Y-37.53%
EPS 5Y-12.83%
EPS Q2Q%12.12%
EPS Next Y59.93%
EPS Next 2Y39.1%
EPS Next 3Y32.31%
EPS Next 5Y25.19%
Revenue 1Y (TTM)-2.05%
Revenue growth 3Y-10.32%
Revenue growth 5Y2.4%
Sales Q2Q%-1.18%
Revenue Next Year-2.96%
Revenue Next 2Y-0.48%
Revenue Next 3Y0.4%
Revenue Next 5Y0.65%
EBIT growth 1Y55.55%
EBIT growth 3Y-22.13%
EBIT growth 5Y-3.01%
EBIT Next Year58.86%
EBIT Next 3Y23.69%
EBIT Next 5Y17.45%
FCF growth 1Y9.93%
FCF growth 3Y52.48%
FCF growth 5Y25.91%
OCF growth 1Y0.58%
OCF growth 3Y34.97%
OCF growth 5Y24.1%